Dr Mark S Hoss, OD in Anchorage, AK - Optometrist

Dr Mark S Hoss, OD is a Optometrist based in Anchorage, Alaska. Dr Mark S Hoss is licensed to practice in Alaska (license number 234) and his current practice location is 4341 Tudor Centre Dr, 2nd Floor, Anchorage, Alaska. He can be reached at his office (for appointments etc.) via phone at (907) 729-8624.

NPI number for Dr Mark S Hoss is 1942250519 and his current mailing address is 4201 Tudor Centre Dr, Suite320, Anchorage, Alaska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1942250519.

Contact Information

	Dr Mark S Hoss, OD
	4341 Tudor Centre Dr, 2nd Floor, Anchorage, AK 99508-5904
	(907) 729-8624
	Not Available

Healthcare Provider's Profile

Full Name	Dr Mark S Hoss
Gender	Male
Speciality	Optometrist
Location	4341 Tudor Centre Dr, Anchorage, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1942250519
Provider Enumeration Date: 05/12/2006
Last Update Date: 12/26/2012

Medical Identifiers

Medical identifiers for Dr Mark S Hoss such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942250519	NPI	-	NPPES
OD9052	Medicaid	AK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	234 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark S Hoss is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark S Hoss, OD 4201 Tudor Centre Dr, Suite320, Anchorage, AK 99508-5904 Ph: (907) 729-8624	Dr Mark S Hoss, OD 4341 Tudor Centre Dr, 2nd Floor, Anchorage, AK 99508-5904 Ph: (907) 729-8624

News Archive

Scientists reveal complex protein mechanism that regulates genes linked with cancer

Scientists at Memorial Sloan-Kettering Cancer Center in New York and at IRB Barcelona reveal the mechanism of action of a protein that is essential for life and is associated with disease.

Four-year study to test effectiveness of WHO Safe Childbirth program

Harvard School of Public Health (HSPH) has been awarded a $14.1 million, four-year grant from the Bill & Melinda Gates Foundation to test the effectiveness of an innovative checklist-based childbirth safety program in reducing deaths and improving outcomes of mothers and infants in 120 hospitals in India.

Lung cancer in smokers versus non-smokers shows different genetic mutations

A group of scientists at B.C. Cancer Agency have found that lung cancers in smokers have different genetic mutations and look different than lung cancer in non-smokers. According to senior scientist at the BC Cancer Agency Research Centre Wan Lam, this finding is significant because it means that from now on, research, treatments and diagnostics should be tailored to the distinct genetic variations in the different lung cancers instead of expecting that a one-size fits all approach will work. He said, "At the current time, treatment does not distinguish between these different types. The subtypes are all grouped together. But with this work, we are beginning to tease out the subtypes." The study was presented Tuesday at a conference in Philadelphia of the American Association of Cancer Research.

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

Optometrist in Anchorage, AK

Dr. Gary Michael Kjome, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515 Phone: 907-349-6932 Fax: 907-349-6347
Marko J Hrgovic, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Debarr Rd, Anchorage, AK 99508 Phone: 907-269-9542 Fax: 907-269-9541
Dr. Patrick Reber, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1345 W 9th Ave, Anchorage, AK 99501 Phone: 907-272-2557 Fax: 907-274-4932
Makar Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4411 Business Park Blvd, Bldg. M Ste 10, Anchorage, AK 99503 Phone: 907-770-6652 Fax: 907-770-3668
North Star Optical, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5710 Denali St, Anchorage, AK 99518 Phone: 907-444-8854 Fax: 888-612-1315
Victoria Ann Blower, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 207 E Northern Lights Blvd, Ste 101, Anchorage, AK 99503 Phone: 907-272-9800 Fax: 907-277-1398
Dimond Vision Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515 Phone: 907-349-6932 Fax: 907-349-6347

Dr Mark S Hoss, OD - Optometrist in Anchorage, AK